PubMed Health⌕ Search

Biomedical subjects

D Storek

Publications and source records attributed to D Storek.

4 recordsLinked to original sources

Highly flexible self-expanding meshed metal stents for palliation of malignant esophagogastric obstruction.

BACKGROUND AND STUDY AIMS: Palliative treatment methods for esophageal and cardiac cancer include dilation, laser vaporization and other thermal methods, alcohol injection, and stent insertion. None of these procedures, however, has proved to be a simple, well-tolerated, and lasting method. We present here our results with a new, highly flexible self-expanding metal stent made of nitinol, which is considered to be particularly useful for difficult (long and tortuous) malignant strictures. PATIENTS AND METHODS: From November 1991 to December 1994, 114 patients with unresectable esophagogastric malignancies or tumor recurrences (92 men, 22 women, mean age 64 years) were treated using 138 highly flexible meshed self-expanding metal stents. Regular clinical and endoscopic follow-up was performed, and stent obstruction or overgrowth was treated by argon plasma coagulation (APC). Patients were followed up until death (n = 78; average follow-up 17 weeks, range 1-90 weeks). Thirty-six patients were alive in December 1994 and had had an average of 20 weeks of follow-up (range 1-160 weeks). RESULTS: Stent insertion was technically successful in 97% of cases, and led to a reduction of dysphagia (graded 0-4) from a mean score of 3.5 to a mean score of 1.5. Preparatory treatment to open tight strictures was necessary in 80% of cases. Balloon dilation to support stent expansion was carried out in 42 patients (37%). During follow-up, tumor ingrowth occurred in 66% of cases after a mean of seven weeks, and was successfully treated by APC. Including preparatory treatment and re-treatment, patients underwent a mean of 3.5 endoscopic procedures (range 1-12 procedures), which led to good clinical success in 73% of cases. Ninety-six percent of the patients continued to be able to swallow (dysphagia score < or = 2) during follow-up. CONCLUSIONS: Highly elastic self-expanding metal stents can be successfully implanted in the majority of patients, particularly in those with difficult malignant strictures not easily amenable to other methods. The devices provide good palliation with effective relief of dysphagia, easy handling and implantation, and offer a satisfactory quality of life to the patient. However, tumor ingrowth is a significant problem, even though it can be successfully managed by APC. Adequate covering of the stent that does not affect its mechanical properties or firm anchoring should solve at least some of these problems.

Adolescent↗

[Highly flexible self-expanding metal mesh stents: a new kind of palliative therapy of malignant dysphagia].

Metal mesh stents are a new way in the treatment of malignant stenoses. Between 11/91 and 12/93 in 79 patients with malignant stenoses of the esophagus and the esophago-gastric junction 96 highly elastic, knitted, self-expanding nitinol stents (Ultraflex, Boston Scientific) were implanted. Most of the tumors being problematic, preoperated or preradiated, in 78 of 96 implantations endoscopic pretreatment (Laser, Argon Plasma Coagulation (APC), dilatation)--mostly in the same session--was necessary. Follow up time was 21 (2-108) weeks. In this pilot study 3.5 (1-27) controlendoscopies with 2.5 (1-10) endoscopic interventions were performed. 90 of 96 implantations were primarily successful and led to a functional success in 73 of 79 patients. The ability to swallow improved significantly, the score of dysphagia improved from 3.5 to 1.0 (p < 0.001). There were no relevant complications and no stent-related mortality. All stents could be kept patent during the follow up period using the new developed Argon-plasma-coagulation (APC) to treat the ingrowth of granulation tissue or tumor, which was observed during follow up in 72 of 93 implantations. Tumor ingrowth represents the main problem of the method and demands endoscopic posttreatment (APC) in cases with relevant re-obstruction. Impairment of the stent lumen by tumor ingrowth (granulation tissue plays no role) would have been observed in about 60% of the patients without such a treatment.(ABSTRACT TRUNCATED AT 250 WORDS)

Aged↗

Endoscopic argon plasma coagulation (APC) first clinical experiences in flexible endoscopy.

Argon plasma coagulation (APC) is a new mode of non-contact electrocoagulation in which current is applied to tissues by means of ionised argon gas (argon plasma). In open surgery, APC is used for the haemostasis of superficial, diffuse haemorrhages from parenchymatous organs and for the devitalization of various tissues. Experimental studies have shown the superiority of APC to standard electrocoagulation modes and surgical techniques due to its efficiency and limited tissue traumatisation. After developing and designing special probes which can be applied through flexible endoscopes and after testing these in in vitro studies, we have been able to utilise APC in both the gastrointestinal tract and the tracheobronchial system. From June, 1991 to September, 1992, 102 patients were treated endoscopically in 189 sessions with APC in the upper and lower gastrointestinal tract as well as in the respiratory system. The indications were malignant and benign tumours, diffuse haemorrhages of various origins and sites, tissue overgrowth after stent implantation, tissue remnants after endoscopic adenomectomy, and the conditioning of fistulas prior to fibrin sealing. In all cases, APC in flexible endoscopy was highly effective and easy to perform, with advantages over standard electrocoagulation. No problems or complications were observed. The limited depth of tissue coagulation (2-3 mm) with concomitant, efficient tissue coagulation allows application even in critical areas where there is risk of perforation, such as the duodenum or colon. For many indications, APC has replaced the Nd:YAG-laser, which was formerly used widely in our unit, Except for vaporisation of extended tumours, the APC shows remarkable advantages in nearly all applications.(ABSTRACT TRUNCATED AT 250 WORDS)

Adult↗

[Endoscopic argon gas coagulation--initial clinical experiences].

Argon-gas-coagulation represents a new method of contact free electrocoagulation, where RF-energy is applied to the tissue by means of ionized argon-gas. In the operative field argon-gas-coagulation has been used with success for hemostasis in several parenchymatous organs and for devitalization of various tissues. Experimental studies have shown the superiority of argon-gas-coagulation over standard electrocoagulation and surgical techniques due to its high efficiency and limited tissue traumatization. Having developed and designed special endoscopic probes and after in-vitro-studies we could utilize the method in flexible endoscopy as well. From June 1991 to September 1992, 102 patients were treated in 189 sessions with argon-gas-coagulation in the upper and lower gastrointestinal tract as well as respiratory system. The indications were: malignant and benign tumors, diffuse hemorrhages of various origins and of various sites, tissue overgrowth after stent-implantation, remaining tissue after endoscopic adenomectomy and conditioning of fistulas prior to fibrin sealing. In all cases argon-gas-coagulation in flexible endoscopy has been shown to be a very effective and easy to perform technique with advantages in comparison to standard electrocoagulation. Problems and complications have not been observed. The limited depth of tissue penetration (2-3 mm) coincident with efficient tissue coagulation allows the application even in critical areas such as the duodenum or colon. In many indications argon-gas-coagulation has replaced the former widely used Nd-YAG-laser in our unit. Except vaporisation of extended tumors, the argon-gas-coagulator shows remarkable advantages for nearly all applications.(ABSTRACT TRUNCATED AT 250 WORDS)

Adenomatous Polyposis Coli↗